Literature DB >> 10027308

A photodynamic pathway to apoptosis and necrosis induced by dimethyl tetrahydroxyhelianthrone and hypericin in leukaemic cells: possible relevance to photodynamic therapy.

G Lavie1, C Kaplinsky, A Toren, I Aizman, D Meruelo, Y Mazur, M Mandel.   

Abstract

The mechanism of cell death induction by dimethyl tetrahydroxyhelianthrone (DTHe), a new second-generation photodynamic sensitizer, is analysed in human leukaemic cell lines in comparison with the structurally related hypericin. DTHe has a broad range of light spectrum absorption that enables effective utilization of polychromatic light. Photosensitization of HL-60 cells with low doses of DTHe (0.65 microM DTHe and 7.2 J cm(-2) light energy) induced rapid apoptosis of > or =90% of the cells. At doses > or =2 microM, dying cells assumed morphological necrosis with perinucleolar condensation of chromatin in HL-60 and K-562 cell lines. Although nuclear fragmentation that is characteristic to apoptosis was prevented, DNA digestion to oligonucleosomes proceeded unhindered. Such incomplete apoptosis was more prevalent with the related analogue hypericin throughout most doses of photosensitization. Despite hypericin being a stronger photosensitizer, DTHe exhibited advantageous phototoxic properties to tumour cells, initiating apoptosis at concentrations about threefold lower than hypericin. Photosensitization of the cells induced dissociation of the nuclear envelope, releasing lamins into the cytosol. DTHe also differed from hypericin in effects exerted on the nuclear lamina, causing release of an 86-kDa lamin protein into the cytosol that was unique to DTHe. Within the nucleus, nuclear envelope lamin B underwent covalent polymerization, which did not affect apoptotic nuclear fragmentation at low doses of DTHe. At higher doses, polymerization may have been extensive enough to prevent nuclear collapse. Hut-78, CD4+ cells were resistant to the photodynamically activated apoptotic pathway. Beyond the tolerated levels of photodynamic damage, these cells died exclusively via necrosis. Hut-78 cells overexpress Bcl-X(L) as well as a truncated Bcl-X(L)tr isoform that could contribute to the observed resistance to apoptosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10027308      PMCID: PMC2362416          DOI: 10.1038/sj.bjc.6690066

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  27 in total

1.  Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked.

Authors:  J Yang; X Liu; K Bhalla; C N Kim; A M Ibrado; J Cai; T I Peng; D P Jones; X Wang
Journal:  Science       Date:  1997-02-21       Impact factor: 47.728

2.  The importance of light in the anti-HIV effect of hypericin.

Authors:  J B Hudson; L Harris; G H Towers
Journal:  Antiviral Res       Date:  1993-02       Impact factor: 5.970

3.  Hematoporphyrin as a photosensitizer of tumors.

Authors:  T J Dougherty
Journal:  Photochem Photobiol       Date:  1983-09       Impact factor: 3.421

Review 4.  Hematoporphyrin and HPD: photophysics, photochemistry and phototherapy.

Authors:  D Kessel
Journal:  Photochem Photobiol       Date:  1984-06       Impact factor: 3.421

5.  Virucidal activity of hypericin against enveloped and non-enveloped DNA and RNA viruses.

Authors:  J Tang; J M Colacino; S H Larsen; W Spitzer
Journal:  Antiviral Res       Date:  1990-06       Impact factor: 5.970

6.  Photodynamic therapy induces expression of interleukin 6 by activation of AP-1 but not NF-kappa B DNA binding.

Authors:  G Kick; G Messer; A Goetz; G Plewig; P Kind
Journal:  Cancer Res       Date:  1995-06-01       Impact factor: 12.701

7.  Photodynamic therapy induces caspase-3 activation in HL-60 cells.

Authors:  D J Granville; J G Levy; D W Hunt
Journal:  Cell Death Differ       Date:  1997-10       Impact factor: 15.828

8.  Rescue from programmed cell death in leukemic and normal myeloid cells.

Authors:  J Lotem; E J Cragoe; L Sachs
Journal:  Blood       Date:  1991-08-15       Impact factor: 22.113

9.  bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death.

Authors:  L H Boise; M González-García; C E Postema; L Ding; T Lindsten; L A Turka; X Mao; G Nuñez; C B Thompson
Journal:  Cell       Date:  1993-08-27       Impact factor: 41.582

10.  Therapeutic agents with dramatic antiretroviral activity and little toxicity at effective doses: aromatic polycyclic diones hypericin and pseudohypericin.

Authors:  D Meruelo; G Lavie; D Lavie
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

View more
  12 in total

1.  Effects of photodynamic treatment on mesenchymal stromal cells.

Authors:  O O Udartseva; E R Andreeva; L B Buravkova
Journal:  Dokl Biol Sci       Date:  2013-07-03

2.  Impact of photodynamic inactivation (PDI) using the photosensitizer chlorin e6 on viability, apoptosis, and proliferation of human keratocytes in vitro.

Authors:  Jiong Wang; Tanja Stachon; Timo Eppig; Achim Langenbucher; Berthold Seitz; Nóra Szentmáry
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-10-02       Impact factor: 3.117

3.  Effect and mechanism of 5-aminolevulinic acid-mediated photodynamic therapy in esophageal cancer.

Authors:  Xiaohua Chen; Peng Zhao; Fengsheng Chen; Libo Li; Rongcheng Luo
Journal:  Lasers Med Sci       Date:  2010-07-30       Impact factor: 3.161

4.  Photodithazine photodynamic effect on viability of 9L/lacZ gliosarcoma cell line.

Authors:  Leticia C Fontana; Juliana G Pinto; André H C Pereira; Cristina P Soares; Leandro J Raniero; Juliana Ferreira-Strixino
Journal:  Lasers Med Sci       Date:  2017-05-15       Impact factor: 3.161

5.  Mechanisms in photodynamic therapy: part two-cellular signaling, cell metabolism and modes of cell death.

Authors:  Ana P Castano; Tatiana N Demidova; Michael R Hamblin
Journal:  Photodiagnosis Photodyn Ther       Date:  2005-03       Impact factor: 3.631

6.  Structural and functional characterization of the interaction of the photosensitizing probe methylene blue with Torpedo californica acetylcholinesterase.

Authors:  Aviv Paz; Esther Roth; Yacov Ashani; Yechun Xu; Valery L Shnyrov; Joel L Sussman; Israel Silman; Lev Weiner
Journal:  Protein Sci       Date:  2012-06-26       Impact factor: 6.725

7.  PCNA damage caused by antineoplastic drugs.

Authors:  Soo In Bae; Ran Zhao; Robert M Snapka
Journal:  Biochem Pharmacol       Date:  2008-09-06       Impact factor: 5.858

Review 8.  Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions.

Authors:  Demian van Straten; Vida Mashayekhi; Henriette S de Bruijn; Sabrina Oliveira; Dominic J Robinson
Journal:  Cancers (Basel)       Date:  2017-02-18       Impact factor: 6.639

9.  Hypericin-photodynamic therapy leads to interleukin-6 secretion by HepG2 cells and their apoptosis via recruitment of BH3 interacting-domain death agonist and caspases.

Authors:  M Barathan; V Mariappan; E M Shankar; B J J Abdullah; K L Goh; J Vadivelu
Journal:  Cell Death Dis       Date:  2013-06-27       Impact factor: 8.469

10.  Cell death pathways in photodynamic therapy of cancer.

Authors:  Pawel Mroz; Anastasia Yaroslavsky; Gitika B Kharkwal; Michael R Hamblin
Journal:  Cancers (Basel)       Date:  2011       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.